SXC-2023 Cocaine Interaction Study

Conditions: Cocaine Use Disorder Interventions: Drug: SXC-2023; Drug: SXC-2023 Placebo Sponsors: National Institute on Drug Abuse (NIDA); Promentis Pharmaceuticals, Inc.; Altasciences Company Inc.; Technical Resources International, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials